2021-07-02
Legal Press releases
Stockholm, July 2, 2021 - Intervacc AB (“Intervacc”) announced today that the Veterinary Medicines Directorate (VMD) of the United Kingdom has give a positive outcome on their application for a Marketing Authorisation ... Read more
2021-06-17
Legal Press releases
Stockholm, June 17, 2021 - Intervacc AB (“Intervacc”) announced today that the Committee for Medicinal Products for Veterinary Use (CVMP) of the European Medicines Agency (EMA) has adopted a positive opinion, ... Read more
2021-06-09
Legal Press releases
Intervacc AB (publ) has held its Annual General Meeting (”AGM”) on Wednesday 9 June 2021, at which the following resolutions were made.
Due to the continued spread of the coronavirus and the authorities’ ... Read more
2021-06-06
News
This years AGM will be held June 9th 2021 without physical presence of shareholders and shareholder can only can exercise their voting rights by postal voting. A presentation by CEO Andreas Andersson, where he comment ... Read more
2021-05-28
Legal Press releases
Stockholm May 28, 2021 - Intervacc AB (publ) and the Karolinska Institute, KI, announce today that they have extended the contract for the development of a new generation of animal health vaccines using ... Read more
2021-05-21
Legal Press releases
The period in summary
First quarter January 1 – March 31, 2021
- The regulatory process for the Company’s Marketing Authorization Application (MAA) for Strangvac in Europe has proceeded according to plan. On January ... Read more